$7.60
-0.02-0.26%
At Close: -
$7.59
-0.0100-0.13%
After Hours: 7:04 PM EDT
15 minutes delayed
Relay Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Relay Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $-0.69 | $-0.73 | 5.48 % |
Mar 2024 | 2024-05-02 | $-0.62 | $-0.71 | 12.7 % |
Dec 2023 | 2024-02-22 | $-0.67 | $-0.73 | 8.22 % |
Sep 2023 | 2023-11-02 | $-0.54 | $-0.83 | 34.9 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $0 | $80.00K | -100.0 % |
Mar 2024 | 2024-05-02 | $10.01M | $90.00K | 11018.9 % |
Dec 2023 | 2024-02-22 | $0 | $130.00K | -100.0 % |
Jun 2023 | 2023-08-08 | $119.00K | $750.00K | -84.1 % |
Relay Therapeutics (RLAY) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $-0.69, which beat the estimate of $-0.73.
The Actual Revenue was $0K, which missed the estimate of $80K.
Browse earnings estimates, EPS, and revenue on all stocks.